Cargando…
Abnormal alterations of miR-1 and miR-214 are associated with clinicopathological features and prognosis of patients with PDAC
Pancreatic ductal adenocarcinoma (PDAC) is a devastating malignant disease with a poor prognosis. PDAC is known to be difficult to diagnose at an early stage and to exhibit poor recurrence-free prognosis, but there is also a lack of effective treatment and limited knowledge of its biological charact...
Autores principales: | Cheng, Qing, Han, Li-Hua, Zhao, Hai-Juan, Li, Hui, Li, Jian-Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649611/ https://www.ncbi.nlm.nih.gov/pubmed/29085459 http://dx.doi.org/10.3892/ol.2017.6819 |
Ejemplares similares
-
Carvedilol Alters Circulating MiR-1 and MiR-214 in Heart Failure
por: Shirazi-Tehrani, Elham, et al.
Publicado: (2020) -
Dysregulation of miR-15a and miR-214 in human pancreatic cancer
por: Zhang, Xing J, et al.
Publicado: (2010) -
Tumor-suppressing roles of miR-214 and miR-218 in breast cancer
por: LIU, BO, et al.
Publicado: (2016) -
Expression Change of miR-214 and miR-135 during
Muscle Differentiation
por: Honardoost, Maryam, et al.
Publicado: (2015) -
Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis
por: Hao, Mu, et al.
Publicado: (2016)